Building Blocks; Miscellaneous; Pharmaceutical/API Drug Impurities/Metabolites;
Imatinib RC11 is an impurity of Imatinib (Gleevec) (G407000), which is a tyrosine kinase inhibitor. Highly specific for BCR-ABL, the enzyme associated with chronic myelogenous leukemia (CML) and certain forms of acute lymphoblastic leukemia (ALL). It is a COVID19-related research product.